Skip to main content
    O

    Omnicell Inc (OMCL)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $34.00
    -1.44 (-4.06%)

    Market Cap: $1.61B

    Last updated: Nov 17, 2026 at 4:39 PM ET

    Omnicell Inc (OMCL) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Omnicell (OMCL) has a market cap of $1.61B and an enterprise value of $1.46B. Its return on invested capital of 3.01% compares with a 0.13% median across 7 similar companies. Its trailing P/E of 16.9x is below its 10-year median of 28.7x.

    Total Valuation

    Enterprise value is 9.08% below the market cap, as cash exceeds debt.

    Market Cap$1.61B
    Enterprise Value$1.46B
    Latest price (Nov 17, 2026)$34.00

    Key Dates

    The next earnings report is expected on Feb 3, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 3, 2027 (expected)
    Last Earnings DateOct 29, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.62% in the quarter ended Sep 30, 2026 and shrank 0.28% a year over 2 years.

    Shares Outstanding45.89M
    Shares Change (YoY)+0.78%
    Shares Change (QoQ)+0.62%
    Share Count Growth (2Y CAGR)-0.28%

    Valuation Ratios

    Sales and book value multiples are 1.3x and 1.2x. Its year-end P/E ranged from 16.8x to 47.5x from 2016 to 2025.

    P/E Ratio16.9x
    Forward P/E13.8x
    P/S Ratio1.3x
    Forward P/S1.3x
    P/B Ratio1.2x
    P/TBV Ratio3.7x
    P/FCF Ratio10.7x
    P/OCF Ratio8.7x
    PEG Ratio1.8

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 9.3x EBITDA and 9.7x free cash flow.

    EV / Earnings32.8x
    EV / Sales1.2x
    EV / EBITDA9.3x
    EV / EBIT21.8x
    EV / FCF9.7x

    Price Statistics

    The stock is down 3.19% over 52 weeks and trades 3.11% below its 50-day average.

    Beta (1Y)1.03
    52-Week Change-3.19%
    1-Month Change-5.05%
    3-Month Change-6.67%
    6-Month Change-22.41%
    5-Year Change-79.43%
    10-Year Change+12.34%
    Total Return (1Y)-3.19%
    Total Return (3Y CAGR)+0.89%
    Total Return (5Y CAGR)-28.58%
    Return vs SPY (1Y)-12.78%
    Max Drawdown (1Y)-37.28%
    Max Drawdown (3Y)-53.57%
    Sharpe Ratio (1Y)-0.02
    Correlation with SPY (1Y)0.28
    50-Day Average$35.09
    200-Day Average$38.22
    52-Week Range$31.75 to $55.00
    RSI (14 Days)40.4
    Average Volume (20 Days)624.18K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 1.66x current liabilities, and total debt is 0.13x shareholder equity.

    Current Ratio1.66x
    Quick Ratio1.45x
    Debt / Equity0.13x
    Debt / EBITDA1.10x
    Debt / FCF1.16x

    Returns and Efficiency

    Return on invested capital is 3.01% over the last 12 months, against a 5-year average of 1.12%.

    Return on Equity (ROE)3.39%
    Return on Assets (ROA)2.17%
    Return on Invested Capital (ROIC)3.01%
    Return on Capital Employed (ROCE)4.25%
    ROE (5Y Average)1.35%
    ROA (5Y Average)0.73%
    ROIC (5Y Average)1.12%
    Asset Turnover0.62x
    Inventory Turnover7.00x
    Receivables Turnover5.37x
    Cash Conversion Cycle91 days

    Taxes

    Income tax took 33.57% of pretax income over the last 12 months.

    Income Tax (TTM)$22.58M
    Effective Tax Rate33.57%

    Scores

    OMCL has an Altman Z-Score of 2.45, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score2.45
    Altman Z ZoneGrey
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $1.24B over the last 12 months is up 5.62% from the 12 months before.

    Revenue$1.24B
    Revenue Growth (YoY)+5.62%
    Gross Profit$561.45M
    Operating Income$64.65M
    Pretax Income$67.24M
    Net Income$44.66M
    EBITDA$152.59M
    EBIT$67.24M
    Reported EPS (TTM)$2.01

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 64.08% of the $2.06B in total assets.

    Cash and Equivalents$314.86M
    Total Debt$168.51M
    Net Cash$146.35M
    Net Cash Per Share$3.19
    Working Capital$310.28M
    Shareholder Equity$1.32B
    Book Value Per Share$28.70
    Tangible Book Value$423.76M
    Tangible Book Per Share$9.23
    Total Assets$2.06B
    Total Liabilities$739.58M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $40.45M of capital spending, operating cash flow left $145.77M of free cash flow.

    Operating Cash Flow$186.22M
    Capital Expenditures$40.45M
    Free Cash Flow$145.77M
    FCF Per Share$3.21
    Depreciation and Amortization$85.35M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 5.20%, against a 5-year average of 1.03%.

    Gross Margin45.14%
    Operating Margin5.20%
    Pretax Margin5.41%
    Net Margin3.59%
    EBITDA Margin12.27%
    EBIT Margin5.41%
    FCF Margin11.72%
    Gross Margin (5Y Average)44.52%
    Operating Margin (5Y Average)1.03%
    Net Margin (5Y Average)1.37%

    Growth

    Revenue fell 2.94% a year over 3 years, and EPS 18.57% a year.

    Revenue Growth (3Y CAGR)-2.94%
    Revenue Growth (5Y CAGR)+5.84%
    EPS Growth (3Y CAGR)-18.57%
    EPS Growth (5Y CAGR)-8.60%
    FCF Growth (3Y CAGR)+42.16%
    FCF Growth (5Y CAGR)-11.83%
    Book Value Per Share Growth (2Y CAGR)+2.39%
    Tangible Book Per Share Growth (2Y CAGR)+16.36%

    Revenue and profit by year

    Dividends and Yields

    OMCL does not pay a dividend. Its free cash flow yield is 9.34%.

    Earnings Yield5.92%
    FCF Yield9.34%
    Buyback Yield-1.01%
    Shareholder Yield-1.01%

    Peer Position

    Against 7 similar companies, OMCL has the 6th highest P/E and the 3rd highest ROIC.

    P/E Ratio16.9x vs 35.0x median
    P/S Ratio1.3x vs 2.5x median
    ROIC3.01% vs 0.13% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.62% vs +11.38% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 2.29% and EPS growth at 11.36% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+2.29%
    EPS Growth Forecast (2Y CAGR)+11.36%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About OMCL

    What is OMCL's market cap?

    Omnicell has a market cap of $1.61B. Its enterprise value, which adds debt and subtracts cash, is $1.46B.

    What is OMCL's P/E ratio?

    Omnicell has a trailing P/E ratio of 16.9x and a forward P/E of 13.8x.

    How many shares of OMCL are outstanding?

    Omnicell has 45.89M shares outstanding. The count is up 0.78% from a year earlier.

    Does OMCL pay a dividend?

    No. Omnicell does not pay a dividend.

    How much debt does OMCL have?

    Omnicell has $168.51M of total debt and $314.86M of cash and equivalents, a net cash position of $146.35M.